EV/EBITDA:
-12.78+0.17(+1.31%)Summary
- As of today, VKTX EV/EBITDA is -12.78, with a rise of +0.17 (+1.31%) during the current trading session.
- Over the past year, VKTX EV/EBITDA has increased by +23.21 (+64.49%).
- VKTX EV/EBITDA is now -3751.43% below its all-time high of 0.35.
Performance
VKTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
VKTX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | +1.3% | -1.3% | -1.1% |
| 1M1 Month | -14.0% | +14.0% | +11.4% |
| 3M3 Months | -40.4% | +81.5% | +53.3% |
| 6M6 Months | +1.8% | +56.8% | +35.8% |
| YTDYTD | +46.4% | -2.2% | -7.2% |
| 1Y1 Year | +64.5% | -27.1% | -27.5% |
| 5Y5 Years | -151.1% | +1670.3% | +501.4% |
VKTX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -10.34 | -23.6% | -14.20 | +10.0% |
| 3M | 3-Month | -8.17 | -56.4% | -14.20 | +10.0% |
| 6M | 6-Month | -8.17 | -56.4% | -18.48 | +30.8% |
| 1Y | 1-Year | -8.10 | -57.8% | -38.50 | +66.8% |
| 3Y | 3-Year | -1.91 | -569.1% | -95.77 | +86.7% |
| 5Y | 5-Year | 0.35 | -3751.4% | -95.77 | +86.7% |
| All-Time | All-Time | 0.35 | -3751.4% | -95.77 | +86.7% |
VKTX EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -12.78(+46.4%) |
| 2024 | -23.83(-59.5%) |
| 2023 | -14.94(-80.0%) |
| 2022 | -8.30(-191.2%) |
| Date | Value |
|---|---|
| 2021 | -2.85(+28.2%) |
| 2020 | -3.97(+65.2%) |
| 2018 | -11.42(-893.0%) |
| 2016 | -1.15 |
FAQ
- What is Viking Therapeutics, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Viking Therapeutics, Inc.?
- What is VKTX EV/EBITDA year-to-date change?
- What is Viking Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Viking Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of VKTX is -12.78
What is the all-time high EV/EBITDA for Viking Therapeutics, Inc.?
Viking Therapeutics, Inc. all-time high EV/EBITDA is 0.35
What is VKTX EV/EBITDA year-to-date change?
Viking Therapeutics, Inc. EV/EBITDA has changed by +11.05 (+46.37%) since the beginning of the year
What is Viking Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, VKTX EV/EBITDA has changed by +23.21 (+64.49%)